Showing posts with label Georgia. Show all posts
Showing posts with label Georgia. Show all posts

Friday, May 20, 2011

Davis' Kin: Death Row Families Suffer Most

Martina Correia
Having a loved one on death row would be stressful enough for most people. The trial, sentencing, appeals and the wait to see if there is any possibility that the worst you can imagine may not come to pass can take its toll on anyone’s physical, emotional and mental health.

Martina Correia understands that better than most. The sister of Death Row inmate Troy Davis has been going through that emotional roller coaster for years and wrestling with a number of health issues, including her own battle with Stage IV breast cancer.

Davis, who is black, was convicted and sentenced to death for the 1989 murder of white Savannah policeman Mark MacPhail.

No physical evidence has linked Davis to the killing, and seven of the nine witnesses who implicated Davis at trial have since recanted, saying that they were pressured into naming him. Last year, the presiding judge of an evidentiary hearing in the case ruled that Davis failed to establish his innocence, clearing the way to set a new execution date.

In late March, the U.S. Supreme Court did not address Davis' appeal of the judge's ruling. Barring any other legal remedies, the remaining option would be getting the state of Georgia's Board of Pardons and Paroles to grant him clemency.

The pressure definitely took a toll on Davis’ family. His father died six months after he was convicted; an aunt died 16 months ago, and his mother died in April.

Correia told BlackAmericaWeb.com that within 30 minutes of telling Davis that his mother had died, prison officials also told him he could not have his monthly contact visit with his family. Authorities contended, Correia said, that there was concern about how Davis would react with relatives present so shortly after hearing the news about his mother.

So, beyond just working to see that her brother receives justice in the courts, Correia is also monitoring his treatment in prison while undergoing treatment for breast cancer, raising her teenaged son and caring for her husband, who recently began intensive dialysis treatments.

“I just have a strong faith in God,” Correia said when asked how she manages. “Whenever I have something happening, and it’s too much of a burden for me to carry, I just give it over to God."

She said lawyers for Davis continue to seek legal avenues to have his case heard.

In not hearing Davis’ case in March, Correia said, “They didn’t deny Troy’s case; they didn’t select Troy’s case. There’s a difference,” which may leave an opening for further appeal.

Correia said a new warden was assigned a year ago to the prison where Davis is incarcerated and has taken a hard line on the treatment of death row inmates, including limiting or eliminating contact with families, severely restricting inmates’ physical movement and increasing fines for minor infractions.

“For 20 years, there was no problem until the new warden came in,” she said. “They talk real nice to the family on the phone, and then go antagonize the inmates” to provoke them into committing infractions for which they can be punished.

“They put dog cages on the yard so they can’t go out for recreation. They have to go into these cages that are 5-by-9 or 6-by-9 and just stand. My brother said he hasn’t been outside for a year,” Correia said.

At one time, inmates were allowed to have books in their cells, some minimal art programs, “just things to keep them sane,” but all of those things have been eliminated or severely curtailed.

“The morale is so low that they’ve had suicide attempts and one suicide success. We get outsiders to talk (to officials on Davis’ behalf) because it minimizes the punishment,” Correia said, noting the Georgia state NAACP and the Southern Center for Civil Rights have been helpful go-betweens.

Through it all, she said, her brother has shown resilience. “He asks God if it’s his will to use him to make a bigger statement about innocence, then that’s God’s will."

Beyond getting her brother off death row and getting evidence that could prove his innocence heard, Correia said there is a push to change death penalty law in general. The law, as it is written, doesn’t require a confirmation of guilt, just a guilty verdict.

“The lawyers have told us it is not illegal to execute innocent people in this country if the courts feel they got a fair trial."

In the meantime, Davis’ family and supporters are urging people to go to www.JusticeforTroy.org, and sign the petition calling for his release, link the site to their Facebook pages and get friends to sign the petition too.

“Get Troy’s address from the site, and send him words of encouragement,” Correia said. “Not letters of ‘Woe is me’ and ‘the Department of Corrections sucks’ - which we already know."

Once the execution day is set, a Global Day of Solidarity will be scheduled five to 10 days before the date, with events held in various locations around the world and in Georgia, where Davis is imprisoned.

Correia said she wants people to remember that “both (MacPhail’s and Davis’) families are victims; Death Row families especially because they keep dealing with the uncertainty over the appeals."

“I just think my mother died of a broken heart, but she made sure we were strong enough to deal with this," Correia said. "It’s not just the inmate who is on death row. That whole family is on death row."

Source: blackamericaweb.com, May 19, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Sunday, May 15, 2011

Europe fights the death penalty—with drugs

Danish company manufactures U.S. executioners' anesthetic of choice for lethal injections

BRUSSELS, Belgium — The Danish pharmaceutical company Lundbeck has an ethical dilemma.

It prides itself on making products that improve peoples’ lives. But one is helping put people to death.

Convicted killer Benny Joe Stevens was executed Tuesday in Mississippi’s Parchman State Penitentiary with a lethal injection of the anesthetic pentobarbital made by Lundbeck.

Denmark, like the rest of the European Union, is officially opposed to the death penalty. Lundbeck spokesman Anders Schroll said the company holds that position in the Danish headquarters as well as in its American office.

“This is a misuse of our product,” Schroll said. “We are in an ethical dilemma where we are opposed to the use of our medication for capital punishment while at the same time we want to make sure that patients who benefit from our medication get access to it.”

Pentobarbital also is used in the treatment of seizures in humans and in anesthesia and euthanasia of animals. Only Lundbeck still manufactures the drug for purchase in the United States. Schroll provided letters from doctors urging the company not to withdraw the 50 million doses of the drug sold each year.

For its part, Schroll said Lundbeck has sent letters to prisons in 11 states in recent months demanding they cease using pentobarbital as part of the lethal injection “cocktail” because “this is just not what we stand for” he said. The Danish foreign ministry has pursued the matter through its contacts. No prison has responded. In fact, more and more states are intending to use the drug, with Virginia, the secondmost-active death-penalty state, announcing a switch just this week, following the lead execution state, Texas, earlier this month.

A conundrum

The mid-sized Danish company is left in this “conundrum,” as Schroll put it, because other businesses have put an end to their products’ use in executions. Sodium thiopental was used as the requisite sedative in the lethal mix by all but one of the 36 death-penalty states until very recently. The only U.S. maker of sodium thiopental, Hospira, started running short in summer 2010 and stopped making it altogether in January when it moved its manufacturing facility to Italy, which forbade using it for executions.

The difficulty in obtaining sodium thiopental led to a mad scramble by institutions to obtain it, an effort that in some cases involved the Food and Drug Administration, which had to bypass certain regulations so it could be imported from Britain, where a company called Dream Pharma operated out of a driving school. The desperation of prison authorities and dodgy practices came to light in documents obtained by the American Civil Liberties Union of Northern California and the London-based human rights group Reprieve.

The British government late last year put an emergency export ban on sodium thiopental, after being sued by Reprieve. The U.S. Drug Enforcement Agency has now seized stockpiles of sodium thiopental due to concerns raised about the legality of its import.

But there are also concerns about whether the drug made by Dream Pharma actually worked. The mother of executed Georgia inmate Brandon Rhode came to Europe recently to share the story of what she believes was the agonizing death of her son last year due to defective sodium thiopental. A lethal-injection expert said Brandon’s eyes remained open during his execution, indicating the sedative didn’t work properly. Patches Rohde pleaded with the British government to extend the emergency ban on the drug, saying U.S. authorities had “not only killed Brandon but tortured him … . I beg [you] to keep this torture from happening to anyone else.”

Last month Britain added pentobarbital along with two other lethal-injection drugs to the emergency export ban.

“We oppose the death penalty in all circumstances,” said U.K. Business Secretary Vince Cable, “and are clear that British drugs should not be used to carry out lethal injections.”

Patches Rohde is gratified. Speaking from her home in Mississippi this week, she said, “There’s just no words than can get across how it feels. The fact that Europeans are going to work harder to help people in prison in the U.S. than the people in the U.S. are is just”—she paused cautiously—“it’s shameful for the Americans … but it’s great. It really is.”

_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Saturday, May 7, 2011

Georgia plan would keep 3-drug executions

Georgia's top prison official is considering a plan that would allow the state to stick with a 3-drug combination for lethal injections by substituting a new drug for one seized by federal regulators in March, according to documents obtained by The Associated Press.

The proposal, which is being considered by Corrections Commissioner Brian Owens, would allow the state to use pentobarbital instead of sodium thiopental. The AP obtained the documents through an open records request. There is no timetable for a decision, said Georgia corrections spokeswoman Joan Heath.

State corrections officials have been working on the change since the Drug Enforcement Administration took Georgia's supply of sodium thiopental amid questions of whether the state circumvented the law to obtain the drug amid a nationwide shortage.

Earlier, state officials had visited Ohio, which uses only pentobarbital in lethal injections, and Oklahoma, which uses the sedative as part of a 3-drug combination, to study those procedures.

Most of the nation's 34 death penalty states have scrambled over the last year to find a new supplier of sodium thiopental since its sole manufacturer in the U.S. announced in January it will no longer make the drug. Several states postponed executions amid the shortage, and some have looked overseas to secure a supply.

Georgia's situation was made worse when the state had to surrender its stockpile of the drug after defense attorneys questioned whether the state properly registered with the DEA before importing the drug from London. Documents also show the drug was purchased from a London company that operates at the same address as a driving school.

State officials have said they don't have concerns about the quality of the sodium thiopental and that they are cooperating with investigators. Meanwhile, corrections officials have quietly begun laying the groundwork for a switch, collecting hundreds of pages of legal filings and other documents about the drugs, according to more than 1,000 pages of files reviewed by the AP.

The new procedure would require prison staffers to inject two syringes containing 2.5 grams of pentobarbital each into the death row inmate's bloodstream, followed by a syringe of saline to ensure a steady flow of the drug. After at least 5 minutes, staffers would then inject pancuronium bromide to paralyze the inmate and then potassium chloride to stop the heart.

The plan would also require officials to post a certificate from the DEA certifying the drugs were obtained legally at the medical room of the death chamber, which is housed in the Georgia State Prison in Jackson.

A switch would clear the way for Georgia to schedule the execution of Troy Anthony Davis, who was sentenced to die for the 1989 slaying of an off-duty Savannah police officer. The U.S. Supreme Court in March rejected his most recent legal appeal, but the state couldn't execute him because it didn't have the lethal injection drug.

The switch could also lead to legal challenges from defense attorneys and death penalty opponents. William Montross of the Atlanta-based Southern Center for Human Rights said he hoped Georgia corrections officials consulted with medical authorities in developing the policy.

"This new protocol was developed without public scrutiny and is highly experimental," he said.

Source: Associated Press, May 6, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Friday, April 22, 2011

U.S.: States moving quickly to switch execution drug

San Quentin's new
death chamber
Nearly 2/3 of the 16 states with active death chambers are switching to an alternative sedative for execution -- even as the drug's manufacturer argues against its use in capital punishment and some European countries push to ban the export of such drugs.

10 states, including Texas, have switched to pentobarbital or are considering a switch as part of their 3-drug methods, according to a survey of all death penalty states by The Associated Press.

At issue is a shortage of sodium thiopental, a sedative that states used for more than 3 decades until its only U.S. manufacturer stopped making it in 2009 and dropped plans to resume production this year.

The shortage forced several states to scramble to find new supplies, and executions were temporarily delayed in Arizona, California, Georgia and Oklahoma. States swapped supplies of sodium thiopental or looked overseas, to England, India and even Pakistan.

Several states turned to England and obtained doses of sodium thiopental not approved for medical use in this country by the FDA.

But that source dried up after the British government banned the drug's export for use in executions and the U.S. Drug Enforcement Administration began seizing supplies from Georgia and other states over questions of whether they broke the law to get the drug.

The 10 states that have switched to pentobarbital or are considering a switch are among 16 that held executions in the past 3 years or have executions scheduled this year.

Pentobarbital is used as a sedative in some surgeries, as a hypnotic for short-term treatment of insomnia and as a way to control certain types of seizures.

Anti-death-penalty groups want its Danish manufacturer, Lundbeck Inc., to write clauses into contracts with pharmaceutical distributors to ban its use in executions.

Lundbeck, which strongly opposes the use of its drug for capital punishment, says such clauses would be impractical because of the way drugs are distributed.

"We don't control the full supply chain and how it gets into the hands of the end user," said Lundbeck's U.S. spokeswoman, Sally Benjamin Young.

Once a drugmaker sells its initial supplies to wholesalers, the drugs are shipped to a variety of retailers nationwide that can resell them to licensed medical professionals.

Texas, the country's most active death penalty state, obtained all three of its execution drugs from Besse Medical of suburban Cincinnati, a large pharmaceutical distributor.

The company says it has no way to determine what its customers do with its products.

Source: Associated Press, April 22, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Death-row lawyer: Nebraska bought lethal-injection drug from rogue broker

Kayem Pharma Mumbai office entrance
Source: Reprieve More here
The Nebraska Supreme Court late Thursday rejected a complex appeal by death-row inmate Carey Dean Moore and ordered him to be executed on June 14.

In doing so, the court rejected arguments by Moore's lawyers challenging the legality of Nebraska's purchase from an Indian company of 1 of 3 drugs used in the state's lethal-injection protocol and questioning whether the state even bought the right drug.

Jerry Soucie, a lawyer with the Nebraska Commission on Public Advocacy, had asked the court to order a lower court to hear the issue of the state's purchase.

"The subject matter of the proceeding pending herein is not one which the Nebraska Supreme Court may ‘remand' to a district court," Chief Justice Michael Heavican wrote.

Soucie declined immediate comment.

Meanwhile, court documents filed earlier Thursday said the state might have bought the lethal injection drug from a rogue pharmacy broker who just wanted to make quick money.

The state paid $2,056 to Kayem Pharmaceutical Pvt. Ltd. for 500 grams of sodium thiopental. The drug has been in short supply since last year and the only U.S. manufacturer, Hospira Inc., is ending production because of death-penalty opposition overseas.

But in an email this week to Soucie, the CEO of Kayem said the state bought the drug from a pharmacy broker who deceived the company -- even going as far as registering it to do business in Nevada without its knowledge.

CEO Navneet Verma said an Indian citizen named Chris Harris approached his company last year about being a pharmacy broker for Kayem.

Harris later allegedly told Verma he and another man, Tony Atwater of Steuben, Maine, already had registered the company as a corporation in Nevada under the name Kayem Pharmaceutical LLC.

"This sudden and abrupt formation of a company by this duo has given rise to suspicion about ... deceit by the hands of this duo," Verma said. "... The intention of this duo was clear to us as they wanted to make quick money ... getting themselves in the unethical practices ... detrimental to Kayem Pharmaceutical."

Verma said the sale of the drug was between Harris and Steve Urosevich, chief operating officer for the Nebraska Department of Correctional Services.

He said Kayem simply supplied the drug to Harris. Verma also said the company since has cut ties with Harris.

"The inescapable conclusion is that Chris Harris and Kayem are rogue foreign pharmaceutical brokers/distributors and that the importation of a controlled substance by DCS was in violation of the applicable federal statutes," Soucie wrote in court filings.

Soucie says the address listed by Harris with the Nevada Secretary of State's office is that of a mail forwarding service called "Mostly Mail," which advertises mail boxes for rent.

Harris did not immediately respond to an email request seeking comment.

Atwater said Verma approved of their registering Kayem in Nevada, but the 2 had a subsequent falling out over money and parted ways.

Kayem completed a federal "Certificate of Origin" dated Dec. 8, 2010, that said the drug shipped to the Nebraska Department of Correctional Services was "Thiopentone ... thiosol sodium" manufactured by Neon Laboratories Ltd. of Mumbai, India.

The state's lethal injection protocol calls for using "sodium thiopental." It appears, Soucie said, that the state might have bought a generic version.

"The state's own attachment to the motion for an execution date does NOT allow for the use of ‘thiopentone' or ‘thiosol sodium' as the first of the drugs in the lethal execution cocktail," Soucie said in a motion to the high court asking for a hearing.

He said federal law requires that before a new drug is used in the United States, the manufacturer must file an application with the Food and Drug Administration outlining the drug's safety, composition and manufacturing process, among other things.

To market a generic drug in the United States, a manufacturer must file an application showing the FDA has approved its active ingredients.

Verma said his company is not so licensed. Nor, he said, is Kayem or Neon Laboratories registered with the Drug Enforcement Administration and authorized to deliver controlled substances to the United States.

Soucie said the DEA registration held by the Corrections Department does not authorize it to directly import drugs from a foreign supplier.

The DEA recently seized Georgia's entire supply of sodium thiopental, which defense attorneys say came from a questionable British supplier. The DEA said there were questions about how it was imported.

FDA spokeswoman Shelly Burgess has said the agency could not comment on the Nebraska case. The DEA referred inquiries to the U.S. Department of Justice, which also has declined comment.

Nebraska corrections officials deferred comment to state Attorney General Jon Bruning's office. Said Bruning: "The court order speaks for itself."

In court papers, the attorney general's office said Soucie should not be allowed to ask for a hearing since the high court had been asked to set an execution date for Moore.

In his filing, Soucie wrote, "without evidence of compliance with these federal regulatory requirements, there is no basis upon which to presume the efficacy of these specific drugs obtained from Kayem and that they do not present a ‘substantial' or ‘objectively intolerable risk of harm' during a judicial execution."

According to documents reviewed by the Journal Star, the corrections department paid Phil Patterson Inc., an import company based in Omaha, to facilitate shipment of the drug from India.

Kayem issued the certificate of origin for the drug and the shipment was under the supervision of customs officials in India and the United States, said Megan Cooley, who oversaw the importation for Phil Patterson Inc.

Once the shipment arrived in the United States, it was tested by Medtox Laboratories in St. Paul, Minn., to verify that it was sodium thiopental, according to the documents.

Soucie also questions the legitimacy of Kayem to make a lethal injection drug.

He said Kayem's main facility in India is in a ground-floor apartment in Mumbai.

"There are 2 small rooms, one serving as an office and the other as a storage room," Soucie said. "There is no air conditioning or climate control at this building.

"Kayem Pharmaceuticals does not appear to be involved in the direct formulation of any medications with the exception of Indian herbal remedies to alleviate symptoms of arthritis, upper respiratory infections, constipation, hemorrhoids and inadequate male sexual performance," Soucie said. "Kayem's primary business activity appears to be the production of tablets, capsules, ointments and injectable products as a subcontractor for other generic drug companies located in India."

A federal lawsuit has been filed in Arizona challenging the use of the drugs from overseas suppliers, saying they may be substandard and could lead to problems during executions.

As for the drug Nebraska got, Atwater said it is the real thing.

"It's all legal," he said.

The Nebraska Legislature approved lethal injection as the state's method of execution in May 2009.

Moore, 53, has been on death row since 1980. He was sentenced to die for killing Omaha cab drivers Maynard D. Helgeland and Reuel Eugene Van Ness during botched robberies in 1979.

The state has not executed an inmate since Robert Williams died in the electric chair in 1997.


Source: Lincoln Journal Star, April 22, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Saturday, April 16, 2011

Pennsylvania House Votes to Expand Death Penalty as International Controversy Mounts

Pennsylvania's moves in the opposite direction of the prevailing winds of reform.

On April 6, Sister Helen Prejean, author of the book "Dead Man Walking" and the inspiration for the 1995 film of the same name starring Susan Sarandon as a Catholic nun counseling a condemned prisoner, stood before a packed crowd at Chestnut Hill College in Philadelphia to tell her story and urge attendees -- especially young people -- to join efforts to end capital punishment in Pennsylvania.

"As long as we are not active, as long as we don't raise our voice, as long as we don't resist, we too are responsible," said the fiery, 71 year-old abolitionist.

Her talk couldn't have come at a more dubious time for the death penalty in America.

Since Governor Pat Quinn formally abolished capital punishment in Illinois in March, legislators in no less than half-a-dozen states have introduced bills to repeal the death penalty and replace it with life without parole. States where abolitionist legislation is being considered include three of the death penalty's "big four" -- Texas, Florida and Pennsylvania, which together account for nearly a third of the nation's condemned inmates. (California, which leads the nation with 711 prisoners awaiting execution, has no such legislation pending).

Separately, an international scandal involving a key ingredient used to execute inmates has focused world attention on a U.S. practice that remains out of step with much of the developed world.

Earlier this year Illinois-based Hospira, the only American-based manufacturer of the barbiturate sodium thiopental, chose to stop making it rather than promise authorities in Italy - the site of its new manufacturing facility - that its drug wouldn't be used for capital punishment. Until recently sodium thiopental, sold under the brand name Pentothal, was a primary ingredient in the lethal injection cocktails of 34 states.

Hospira was already facing a shortage of key components used in the manufacture of the drug. The decision to cease production sparked a nationwide shortage of sodium thiopental and forced some states to seek the drug from less reputable overseas suppliers, sparking controversy and in some cases legal intervention.

On March 15 the Drug Enforcement Agency seized Georgia's entire stock of sodium thiopental less than a month after attorneys for inmate Andrew Grant DeYoung notified Attorney General Eric Holder that the Georgia Department of Corrections had imported a quantity of the drug without proper registration from the United Kingdom last July. Since December 2011 Britain has enforced export controls on sodium thiopental.

According to records obtained by attorney John Bentivoglio, the drug came from a small, mom-and-pop wholesaler called Dream Pharma, which ran its operations out of a rented space in the back of a driving school in Acton.

Georgia had already executed two men using the drug, both of whom kept their eyes open during the process. An analysis by the UK-based death penalty abolitionist group Reprieve suggests the quality of the sodium thiopental may have been compromised by poor storage, and both inmates were likely partially conscious throughout the execution process -- a grueling experience according to anesthesiologists .

"At last someone is paying attention to the shenanigans that have been going on with the fly-by-night company exporting large quantities of execution drugs from Britain," said Reprieve's Director Clive Stafford Smith, commenting on the DEA's action.

Kentucky and Tennessee responded to the seizure by turning over their entire stocks of sodium thiopental to federal authorities, but at least 5 other states are reported to have acquired the drug overseas. Last week The Times of India revealed that at least 2 states, Nebraska and South Dakota, were using a Mumbai-based company as their supplier; on April 6, the company, Kayem Pharmaceutical, said it would no longer ship the drug to the U.S.

Pennsylvania - where more than 200 condemned inmates sit on death row -- has so far refrained from entering the debate, and no published reports exist outlining its plans as sodium thiopental becomes less available.

Susan McNaughton, communications director at the Pennsylvania Department of Corrections, declined to comment on the supplier of the state's sodium thiopental, or if it maintained a stock of the drug, but said the DOC is "reviewing its options" as to how the issue surrounding the availability of the drug will affect the execution process in Pennsylvania, if at all.

"We have no reason to think that we are not prepared to carry out executions," she said.

A request under Pennsylvania's Right to Know Law for information on who supplies Pennsylvania's execution drugs, whether or not they are stockpiled and how often the stocks are rotated was pending at press time.

The fact that the state hasn't hosted an execution in more than a decade certainly makes the situation seem less than urgent. However, according to the drug's guidelines, the average shelf life for sodium thiopental is 4 years, meaning the state would need to rotate stocks at least that frequently, or would need to order it before an execution proceeds.

Seeking to circumvent the controversy, some prisons have decided to abandon sodium thiopental altogether. Last month Ohio became the first state to execute an inmate with a single dose of pentobarbital - a short-acting barbiturate commonly used to euthanize animals -- while several others states have said they will begin using pentobarbital in place of sodium thiopental as 1 of 3 execution drugs. That decision is already raising challenges from defense attorneys who say the new drug is unproven and that some states, Texas for instance, have not followed the correct protocol for making such a change.

Meanwhile, many European governments have stepped up efforts to ensure they are not complicit in a practice they oppose. On April 1, Germany petitioned the European Union to consider banning sodium thiopental for exportation to countries where it could be used for execution, and legislators in the UK are lobbying the government to add the other 2 drugs commonly used in lethal injections -- potassium chloride and pancuronium bromide -- to the country's list of banned exports. Given European sentiment concerning capital punishment, pentobarbital may one day face the same fate. With as much as 40 % of pharmaceuticals now being made outside the United States, the implications could be reaching.

Death penalty opponents say the international outcry underscores just how isolated the U.S. is from its allies on the issue of capital punishment.

"This is a sign that it's difficult to do the business of killing people when there are others out there who don't want to participate," said Andy Hoover, Legislative Director of the Pennsylvania American Civil Liberties Union.

PA Legislators push alternate death penalty bills

The day before Sister Prejean visited Chestnut Hill, the Pennsylvania House of Representatives unanimously voted to approve a bill that -- if it passes the GOP-controlled Senate -- could see more inmates sent to death row in the Keystone State.

The legislation -- House Bill 317 -- adds two new aggravating factors to the 18 already considered when determining if the death penalty applies to defendants in murder cases, making capital punishment applicable for defendants that commit sexually violent murder while they are registered sex offenders, as well as those who target the elderly and infirm.

"The House is just completely out of step with reality," said Hoover, commenting on the bill. "They are refusing to accept that this is a broken program. The death penalty was made to be used in limited circumstances, but by adding a category for people that are infirm, which lacks definition, the House is expanding it to where it can be applied to most homicides."

The bill's sponsor, Rep. Kerry Benninghoff, a Republican representing parts of Centre and Mifflin Counties, didn't respond to calls and e-mails seeking comment, but in a statement he said the bill is about "justice, protecting law-abiding citizens and keeping dangerous people off the streets."

Two Democratic senators -- Allegheny County progressive Jim Ferlo, and Daylin Leach -- who represents parts of Delaware and Montgomery Counties -- are seeking to end capital punishment in the Commonwealth.

According to Leach, who in February introduced a bill to place a statewide moratorium on executions, the cost of putting people on Death Row where they'll sit for years through endless appeals just doesn't make any sense given the budget crisis currently facing the state. Studies show it costs more than twice as much in appeals, administration and housing to put an inmate to death than to house him or her for the rest of their lives, while polls show waning support across the nation for the death penalty. The most recent numbers in Pennsylvania show that less than half of respondents favor the death penalty when given the alternative option if life without parole.

"The Death Penalty is just another government program that is too expensive and just not working," said Leach, in an appeal to his conservative colleagues.

Since Pennsylvania reinstated the death penalty in 1977, only three executions have been carried out (the last a dozen years ago), and in all three cases the defendants waved their appeals. It's been nearly half a century since the state executed someone who didn't ask to be. Since then at least 20 condemned inmates have died of natural causes.

Nonetheless, Pennsylvania governors from both parties continue to sign dozens of death warrants, making Pennsylvania's Death Row the fourth largest in the nation. Governor Ed Rendell, a Democrat, signed 119 death warrants during his tenure; and newly minted Republican Governor Tom Corbett has already signed four since taking office in January. There are currently 222 inmates awaiting their execution date, more than half of them Black men from Philadelphia County.

Philadelphia District Attorney Seth Williams supports the death penalty but has said he will use it more conservatively than his predecessor Lynn Abraham, who gained a reputation for aggressively pursuing capital murder charges.

According to Tasha Jamerson, a spokesperson for Williams, the DA's office has filed 11 capital cases since Williams took office, and Jamerson reports a "steady decrease in capital prosecutions since 2003."

The American Bar Association has a theory as to why the Keystone State carries out so few executions despite having so many condemned: Pennsylvania is the only state in the nation that provides no post-conviction financial support for defense appeals, meaning defendants are often required to turn to county services and the aid of less-than-able court-appointed attorneys. As a result, cases are often wildly mismanaged, and regularly overturned on appeal at the expense of taxpayers.

Since 1980, more than 200 death sentences in Pennsylvania have been overturned by federal and state courts, and nearly as many death convictions are vacated in Pennsylvania each year as are handed down.

As states across the country rethink their stance on capital punishment, it's fallen to a handful of "true believers" -like Florida, Texas and Ohio to conduct the majority of America's executions. How long Pennsylvania will continue to count itself among this group remains to be seen, but advocates are confident it's not a matter of if, but when the state will abolish capital punishment.

"It might not be on the first try, it might not be on the second try, but if people keep the pressure on eventually we can change this," said Prejean. "Politicians do eventually listen to the people."

A coalition of 15 statewide abolitionist groups, including Pennsylvanians for Alternatives to the Death Penalty (PADP), The Interfaith Alliance of Pennsylvania, Murder Victims' Families for Human Rights, and the ACLU of Pennsylvania is working hard to see that that they do.

"I think with many changes, it's a question of chipping away, little by little and day by day," said Kathleen Lucas, executive director for PADP. "We will get there. Once our legislators see how broken the system is, I believe that they'll do the right thing. The evidence is on our side."

Source: alternet.org, April 16, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Wednesday, April 13, 2011

URGENT APPEAL for Troy Davis facing the possibility of his 4th execution date

Troy Davis
Georgia death row inmate Troy Davis is facing the possibility of his fourth execution date in four years after the US Supreme Court dismissed his appeal on 28 March. Doubts persist about his guilt in the crime for which he was sentenced to death two decades ago.

Troy Davis was sentenced to death in 1991 for the murder of police officer Mark Allen MacPhail in Savannah, Georgia in 1989. No physical evidence directly links Davis to the murder – no murder weapon was ever found. The case against Davis primarily rested on witness testimony. Since his trial, seven of nine key witnesses have recanted or changed their testimony, some alleging police coercion.

In 2009, the US Supreme Court ordered a federal evidentiary hearing to review Troy Davis’ innocence claim.

At the hearing in June 2010, US District Court Judge William Moore addressed not whether the state could demonstrate a watertight case against Troy Davis, but whether Davis could show “by clear and convincing evidence that no reasonable juror would have convicted him in the light of the new evidence” that had emerged since his 1991 murder trial. Under this “extraordinarily high” standard, Judge Moore wrote, “Mr Davis is not innocent”. Elsewhere in his ruling, however, he acknowledged that the new evidence presented by Troy Davis cast “some additional, minimal” doubt on his conviction, and that the state’s case was not “ironclad”. In 1991, the jury had found Troy Davis guilty “beyond a reasonable doubt,” Judge Moore noted, “but not to a mathematical certainty”.

On 28 March, the US Supreme Court refused to take the Davis case, clearing the way for Georgia to set an execution date. Troy Davis was less than 24 hours from execution in 2007 when the Georgia Board of Pardons and Paroles issued a stay. The Board said in 2007 that it would not allow an execution to go ahead “unless and until its members are convinced that there is no doubt as to the guilt of the accused”. Since then Troy Davis has faced two more execution dates, both in 2008, which were stayed by the courts.

Since 2007, three states in the USA have legislated to abolish the death penalty. When signing the abolitionist bills into law the three state governors all pointed to the risk of irrevocable error as a reason to support abolition. Since Troy Davis has been on death row, more than 90 prisoners have been released from death rows around the country on grounds of innocence. In each case, at trial the defendant had been found guilty beyond a reasonable doubt.

BACKGROUND INFORMATION
In the past four years, three states in the USA – New Jersey, New Mexico and Illinois – have legislated to abolish the death penalty. Signing the bills in law, the three governors pointed to the risk of irreversible error in an imperfect system as a reason to support abolition. In 2007, New Jersey Governor Jon Corzine said that “government cannot provide a foolproof death penalty that precludes the possibility of executing the innocent”. In 2009, Governor Bill Richardson of New Mexico said that to carry out an irrevocable punishment, “we must have ultimate confidence – I would say certitude – that the system is without flaw or prejudice.” This, he added, “is demonstrably not the case”. In March 2011, Illinois Governor Pat Quinn said that the capital justice system was “inherently flawed”, and that it was “impossible to devise a system that is consistent, that is free of discrimination on the basis of race, geography or economic circumstance, and that always gets it right.” He said that, “as a state, we cannot tolerate the executions of innocent people because such actions strike at the very legitimacy of a government”.

More than 130 people have been released from death rows across the USA since 1976 on the grounds of innocence. Among other things the cases reveal the frequent unreliability of witness testimony. The Troy Davis case is one in which most of the witnesses who testified against the defendant have since retracted or contradicted their trial testimony in sworn statements. Nevertheless, a prisoner seeking to rely on revised witness testimony faces a high hurdle in the face of deference to the original jury verdict. At the June 2010 evidentiary hearing in US District Court, the Georgia prosecutor argued that “every court in the United States at every level has said, recantations are not favoured, they are looked at with great scepticism, they’re unreliable.” She concluded about the Troy Davis case: “This was their chance. The standard is extremely high…, they have not met it”.

One of the witnesses who appeared at the hearing was Benjamin Gordon, who in 2008 had signed a statement that an alternative suspect (a relative of his by marriage) had told him that he had shot Officer MacPhail. At the hearing, Benjamin Gordon asserted for the first time that he had actually seen this individual shoot the police officer. Benjamin Gordon, who had just turned 16 at the time of the crime, again alleged that he had been coerced by police into signing a statement implicating Davis. He said that he had not come forward sooner with the assertion about seeing who shot the officer out of fear, and that he had decided to “come in today and just let the truth be known”. Judge Moore concluded that Benjamin Gordon was “not a credible witness”.

The international community has agreed safeguards for capital cases in those countries that still retain the death penalty. One of these concerns the burden of proof on the death penalty state: “Capital punishment may be imposed only when the guilt of the person charged is based upon clear and convincing evidence leaving no room for an alternative explanation of the facts”. The “extraordinarily high” burden of proof chosen by Judge Moore is less protective than this.

Amnesty International opposes the death penalty in all cases, unconditionally, regardless of questions of guilt or innocence, the crime in question, or the method of execution. There have been 1,246 executions in the USA since judicial killing resumed there in 1977, including 12 so far this year. Georgia currently does not have the drugs necessary to carry out a lethal injection after the Drugs Enforcement Administration of the US Department of Justice seized sodium thiopental in the possession of the state in order to conduct an investigation into how it was obtained. It is not known how long this may delay an execution date being set.

For further information on the Troy Davis case, see USA: ‘Unconscionable and unconstitutional’: Troy Davis facing fourth execution date in two years, May 2009, http://www.amnesty.org/en/library/info/AMR51/069/2009/en ; USA: Less than ‘ironclad’, less than safe, 27 August 2010, http://www.amnesty.org/en/library/info/AMR51/077/2010/en

RECOMMENDED ACTION: Please send appeals to arrive as quickly as possible:
-Acknowledging the seriousness of the crime for which Troy Davis was sentenced to death;
-Noting that doubts persist in the case even after the federal evidentiary hearing in 2010;
-Pointing out that the Board acts as a failsafe against irreversible error, and recalling its statement in 2007 that it would not allow any execution to proceed where there was any doubt about the guilt of the prisoner;
-Pointing to the substantial evidence of the fallibility of the capital justice system;
-Calling on the Board to grant clemency and to commute the death sentence of Troy Davis.

APPEALS TO:

State Board of Pardons and Paroles
2 Martin Luther King, Jr. Drive, SE
Suite 458, Balcony Level, East Tower
Atlanta, Georgia 30334-4909, USA
Salutation: Dear Board members

PLEASE SEND APPEALS IMMEDIATELY.
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Monday, April 11, 2011

California's lethal injection drug passes lab tests

New execution chamber
at San Quentin prison
The California Department of Corrections and Rehabilitation’s supply of a key lethal injection drug is lab-certified as sterile and sufficiently potent.

Prison officials sent off a share of their sodium thiopental for testing in January to confirm the drug was manufactured properly. The department purchased 521 grams of the anesthetic in October from an obscure pharmaceutical wholesaler in London.

With the reassuring results (report here), perhaps the lone remaining concern about California’s supply is whether it will fall within an expanding federal inquiry. The U.S. Drug Enforcement Administration is investigating how officials in Georgia, Kentucky and Tennessee imported sodium thiopental, the first of a three-drug cocktail that renders condemned inmates unconscious.

Federal agents have taken possession of imported lethal injection drugs from the three states, the Associated Press reported. Sodium thiopental is in extremely short supply in the United States, prompting some states to share their reserves, or to purchase the drug from overseas.

The latter scenario is becoming the new norm for prison systems that rely on that specific anesthetic. But anti-death penalty groups and condemned inmates have raised questions about whether the imported drug meets U.S. quality control standards.

If the drug does not work as intended, inmates would likely experience extreme pain, violating their Eighth Amendment rights against cruel and unusual punishment.

Food and Drug Administration records show Georgia secured its doses [PDF] from the same vendor as California: Dream Pharma, a one-man operation run from the back of a London driving school.

It remains unknown whether California used the same importers to move the drugs from port to prison.

E-mail correspondence between state and federal officials [PDF] show the corrections department sought the DEA's advice on how to legally import the anesthetic last year.

A DEA agent, whose name has been redacted, on Oct. 4 provided Scott Kernan, corrections department undersecretary for operations, with a spreadsheet listing all approved sodium thiopental importers.

A few days earlier, the corrections department tried unsuccessfully to get a waiver that would have allowed it to import the anesthetic itself. John McAuliffe, a corrections department contract employee, was rebuffed by a DEA official, who wrote that such approval would have to come from someone “above him.”

To which, Kernan replied: “When he responds please get a name and number of superior who can approve an exemption for this specific purpose. I’ll call or even get Matt or somebody in Gov’s office to call.”

The “Matt” referenced is likely Matt Cate, the state corrections secretary.

The American Civil Liberties Union of Northern California obtained the records through Freedom of Information Requests to the federal agency. The organization also forced release of more than 1,000 pages of state records on the lethal injection drug by suing CDCR.

No matter how it arrived at San Quentin State Prison, analysis records released this week show the sodium thiopental meets quality standards. The lab report states that pharmacological potency of tested doses was 93.7 percent, with acceptably low levels of heavy metals and impurities.

Source: California Watch, April 11, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Friday, April 8, 2011

Merchants of death

An execution-frenzy may have been unleashed among death penalty U.S. States with execution drugs successfully sourced from India's Kayem Pharma Company. Will Indian authorities now tacitly condone the entry of generic drug manufacturers into a bloodthirsty niche of global commerce?

Brandon Rhode (31) was not in good shape when he was strapped into the execution chamber gurney on September 27 2010, in Georgia, United States. Six days earlier he had attempted suicide because, according to court documents, he did not want to be “put down like a dog.” As a result, he was left with “deep gaping wounds” from the razor he used to slash his neck and elbows. He was also said to have been brain-damaged from sheer blood loss.

Unfortunately for Rhode, convicted in 2000 of killing three persons during a burglary attempt, the worst was yet to come. For although medics spent 30 minutes trying to find a vein in Rhode's arm, into which they could insert needles to administer lethal drugs, something was clearly going wrong when the drugs started pumping. The first drug injected into Rhode, sodium thiopental, was supposed to render him unconscious, yet Rhode's eyes remained open throughout the procedure and moments before he was pronounced dead he was said to have turned his head and exposed the bandage over his slashed neck.

In a sworn declaration Mark Heath, a medical doctor and an expert witness in lethal injection cases, said: “Given the highly unusual provenance of the thiopental that was used in the Rhode execution, one explanation for the eyes remaining open is that the thiopental lacked efficiency.”

The “unusual provenance” that Dr. Heath mentioned in his report was a reference to the fact that the Georgia Department of Corrections (DOC) had imported the thiopental from Dream Pharma, a company located in the United Kingdom, “which operates out of the back of a driving school in London,” according to Dr. Heath.

Why did a key death penalty State of the U.S., itself a country steeped in a long and contentious history of capital punishment, have to resort to importing a lethal injection drug? A little bit of background is in order here, especially because since January execution drugs have entered the U.S. from yet another “unusual provenance” — Kayem Pharma Company of Mumbai, India.

While the history of the lethal injection goes back to May 1977, when the Oklahoma legislature first adopted it as a statute-supported method of execution, today 37 of the 38 death penalty States have lethal injection statutes. However, the entire execution “industry” in the U.S. relied on only one company for the supply of the lethal drugs cocktail — a firm called Hospira located in Lake Forest, Illinois. Emails, obtained by The Hindu, between Hospira and the Nebraska DOC, importer of thiopental from Kayem Pharma, made it clear that Hospira “do not support the use of any of our products in capital punishment procedures.”

Matters took a turn for the worse for States such as Nebraska when Hospira announced in the summer of 2010 that it had temporarily ceased production of thiopental due to a “shortage of raw materials.” Yet, according to Clive Stafford Smith, Director of a U.K.-based anti-death-penalty campaign group called Reprieve, the reason for the stoppage was that Hospira's plant was old and re-tooling it would be uneconomical given that thiopental is now off-patent.

Italy's stance

When Hospira sought to supply thiopental from a plant it owned in Italy, Reprieve campaigners worked with the Italian government, which was said to have been “shocked that Italy might be involved in the execution business,” and eventually “suggested to Hospira Italy that if they exported any drugs used for executions they might end up losing their export licence altogether.” At this point, according to Mr. Smith, Hospira made the “sensible decision” to cease production of the drugs altogether.

With the supplies of thiopental dwindling rapidly around the U.S., death penalty States saw themselves faced with two options. First, some of them, such as Ohio, Arizona, Oklahoma and Texas, switched to another anaesthetic, pentobarbital, commonly used for euthanising animals, and whose effects on human beings for execution purposes has never been tested.

States such as Ohio and Oklahoma have already executed four prisoners using pentobarbital, despite anaesthesia specialists such as David Waisel of Harvard Medical School warning that “the use of pentobarbital as an agent to induce anaesthesia has no clinical history... [and] puts the inmate at risk for serious undue pain and suffering.”

Act of desperation

In what might well have been an act of desperation, State executioners then decided to start importing thiopental, in the first instance from Dream Pharma in the U.K. Scarcely imagining the enormity of the legal backlash that would ensue, Arizona led the way, quickly executing Jeffrey Landrigan on October 25 2010 using the British thiopental. Georgia followed suit, executing Emmanuel Hammond on January 25 2011, having already executed Rhode.

The instant it was revealed in the British media that a home-grown company was supplying lethal drugs for U.S. executions, there was a flurry of public and legal campaigns mostly targeting two Liberal Democrats, Business Secretary Vince Cable and Foreign and Commonwealth Office Minister of State Jeremy Browne.

They initially declined to intervene; however they reversed that decision, reportedly after seeing evidence that the drug was only being exported for use on death row. Mr. Cable said: “In light of new information I have taken the decision to control the export of sodium thiopental. This move underlines this government's and my own personal moral opposition to the death penalty in all circumstances without impacting legitimate trade.”

The Kayem deal

Enter Nebraska DOC's transactions with Kayem Pharmaceuticals Private Limited, a small generic drug manufacturer based out of Marian Colony in Borivali, Mumbai. A series of emails, which The Hindu has in its possession, began between a representative of the Nebraska DOC and a Kayem sales representative in November 2010, the subject of discussion being the export of 500 one-gram vials of thiopental, valued at $2,056.15, from Mumbai to Nebraska.

The deal appeared to be progressing smoothly until the shipment reached Omaha around mid-December. A hold-up occurred at that point owing to the FDA's lack of clarity on whether or not the Nebraska DOC had a sufficient legal basis for importing the lethal drug. The FDA finally relented on January 7, 2011, making what informed observers described as a “political decision to not review the importation of the drugs.” It, however, clarified its position to the Nebraska DOC, saying: “In keeping with established practice, FDA does not review or approve products for the purpose of lethal injection. FDA has not reviewed the products in this shipment to determine their identity, safety, effectiveness, purity or any other characteristics.”

Yet with this action the FDA has risked unleashing an execution-frenzy among thiopental-starved death penalty States.

Already a likely victim of Indian-made thiopental has been identified — Carey Dean Moore (53). He awaits execution in the Nebraska DOC, now the owner of enough Kayem-manufactured thiopental to execute 166 men.

With the U.S.' patchy record of untested anaesthetics that fail to produce the expected unconsciousness, Moore may also expect the same outcome as Rhode, which Dr. Heath described thus: “There is no dispute that the asphyxiation caused by pancuronium [the second, paralytic agent administered] and the caustic burning sensation caused by potassium [the third, heart-stopping agent administered] would be agonising in the absence of adequate anaesthesia.”

Unless last week's seizures of Kentucky's and Tennessee's stocks of imported thiopental by the U.S. Drug Enforcement Agency are repeated in other States and the proliferation of these untested drugs eventually stopped, we could enter a new era of “cruel and unusual punishment” for death row inmates across the country. Already, it is possible that the dubious Indian barbiturate has found its way into the broader healthcare system and reached the DOCs of several States.

India's options

And for India, itself a user of capital punishment, although in the “rarest of rare” cases, it is anybody's guess as to whether authorities will follow the stellar example of the U.K. and Italy and ban the export of lethal drugs to the U.S. Perhaps in a stroke of irony it will be economics rather than morality that will stall the entry of Indian generic drug manufacturers into this bloodthirsty niche of global commerce.

According to Reprieve's Mr. Smith, “Kayem can expect to be party to U.S. litigation for decades. It may have made them a small profit at the start, but they will end up paying lawyers until their profits have vanished one hundred times.”

Indeed, even as Reprieve held a press conference in Mumbai this week to raise awareness of the issue in the country, Kayem announced: “In view of the sensitivity involved with sale of our Thiopental Sodium to various... prisons in USA and as alleged to be used for the purpose of lethal injection, we voluntary declare that we... refrain ourselves in selling this drug where the purpose is purely for lethal injection and its misuse.”

However, if the lethal drugs export persists, even as India clamours for a more prominent place on the world stage, it will have to hide the embarrassing fact that it tacitly condones its merchants of death.

Source: The Hindu, Opinion, Narayan Lakshman, March 8, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Tuesday, April 5, 2011

US death row injection comes from Mumbai firm

MUMBAI: Correctional services in the US are buying sodium thiopental from a little-known firm in Borivli (West) for use in lethal injections to execute death sentences.

Kayem Pharmaceuticals Pvt Ltd, at Marian Colony, shipped a 500-gram consignment of the yellow powder, packed in a hefty 25-kg strongbox, on December 8, 2010, to the Nebraska department of correctional services. Sodium thiopental is generally used along with pancuronium bromide and potassium chloride to create a cocktail with which several states in the US carry out the death sentence by lethal injection. In February this year, Kayem sold another consignment to the South Dakota department of corrections. Executions are yet to be carried out by Nebraska or South Dakota with the drug purchased from Kayem.

Sodium thiopental has been in short supply in the US for about a year after the sole American company that manufactured it ceased production. That has forced American prisons to look abroad. For Nebraska and South Dakota, that search led to the residential Greenfield Cooperative Housing Society in Borivli (West), where Kayem is located. Kayem is a two-room set-up — office and storeroom — with a balcony that doubles as a kitchen.

American prisons have taken flak for purchasing sodium thiopental, used in lethal injections, from overseas. An earlier purchase from the UK apparently degraded by the time it reached American shores, said Clive Stafford Smith, director of Reprieve, an international charity assisting people around the world facing the death penalty. "The failure of the sodium thiopental purchased in the UK has thus far caused the excruciating and torturous death of three people, one in Arizona and two in Georgia," Smith said.

That prompted a lawyer in Nebraska — where the execution of Carey Dean Moore, 53, is pending — to move court there against the use of the sodium thiopental bought from Kayem. There were also questions raised about whether Kayem is properly registered in the US.

Officials in the Nebraska corrections department did not respond to queries emailed by this newspaper. However, replying to the court in the Nebraska case, state solicitor-general J Kirk Brown said: "The state of Nebraska has duly enacted a new statutory method of execution (lethal injection) and adopted an execution protocol pursuant to the statute, which together satisfy all currently understood requirements of our state and federal constitutions."

Kayem, a small-scale Indian company, may now be in a position to increase its business. "Several American states have now approached us for sodium thiopental," said Navneet Verma, director, Kayem Pharmaceuticals. Verma said he sold the first consignment of 500 grams to the Nebraska correctional services at $3.50 a gram. That works out to $1,750, or around Rs 78,000. When officials at the South Dakota department of corrections evinced interest to buy the same drug, Kayem jacked the price up to $10 a gram.

Derived by mixing sodium and thiopentone, the drug sodium thiopental doesn't really require a huge facility to manufacture and goes for around Rs 35 a gram in the Indian market.

Source: The Times of India, April 5, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Saturday, April 2, 2011

Kentucky and Tennessee Turn Over a Drug Used in Executions

Kentucky and Tennessee turned over their supplies of a drug used in executions to the federal authorities on Friday, weeks after Georgia’s supply was seized because of questions about how it had been imported.

Production of the drug, sodium thiopental, a sedative widely used in lethal injections, was discontinued in January after a shortage that lasted months, leaving many states scrambling to find alternative supplies. The drug, which had been manufactured by Hospira Inc., was used in 34 of the 35 states that carry out lethal injections.

Kentucky’s sodium thiopental was “turned over to the D.E.A. for its use as evidence in a case in another jurisdiction,” Jennifer Brislin, director of communications for the Kentucky Justice and Public Safety Cabinet, said in an e-mail. She would not say where the jurisdiction was or comment on the investigation.

“We are fully cooperating with the D.E.A.,” Ms. Brislin said, referring to the Drug Enforcement Administration.

Kentucky obtained its supply of the drug, enough to carry out three executions, from CorrectHealth, a private Georgia correctional health company, Ms. Brislin said, and the drug’s packaging indicated it had been manufactured by an Austrian company.

In March, the drug enforcement agency seized Georgia’s supply of sodium thiopental weeks after records procured by a defense attorney for a man on death row showed that the state had purchased it from a London supplier operating out of a driving school. A Kentucky defense attorney has also questioned the legality of the state’s supply.

The Justice Department declined to comment.

Dorinda Carter, a spokeswoman for the Tennessee Department of Correction, said the department turned had over 44 vials of the drug. The state did “not purchase any drugs from a foreign supplier,” Ms. Carter wrote in an e-mail.

“There is no allegation that TN has done anything improper,” she wrote.

Tennessee has an execution scheduled for Sept. 13, but Ms. Carter did not say what drug would be used.

American plants stopped making sodium thiopental — one of three drugs used in lethal injections — in 2009. Hospira stopped producing it in January after it was unable guarantee to the authorities in Italy, where it was to be made, that it would not be used for capital punishment.

California and Arizona obtained shipments of the drug from England last fall, but the British government has since refused to export drugs used for execution. The Associated Press reported that at least four other states, including Tennessee, had obtained the drug from overseas.

Source: The New York Times, April 1, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Thursday, March 31, 2011

Death Penalty Opponents Assail Troy Davis Ruling

Troy Davis
Anti-death penalty activists criticized the U.S. Supreme Court’s decision to reject without comment death row inmate Troy Davis’ appeals seeking to delay his execution while he attempts to prove he was wrongfully convicted of killing a white police officer in 1991.

Without another appeal, commutation or pardon, Monday’s decision likely will allow the state of Georgia to set another execution date for Davis. There may be a slight delay in scheduling because of questions over the state’s supply of a key lethal injection drug.

Federal regulators seized the entire stockpile of sodium thiopental earlier this month after questions arose about the way the state obtained the drug.

“We are deeply shocked and disappointed because we think that [Davis] has made a compelling case of innocence and that there are too many questions to go forward with his execution,” Diann Rust-Tierney, executive director of the National Coalition to Abolish the Death Penalty, told BlackAmericaWeb.com.

Davis was convicted in 1991 of killing Mark MacPhail, an off-duty Savannah, Georgia police officer, largely on the basis of eyewitness testimony, but 7 of the 9 witnesses who implicated Davis have since recanted, and other witnesses have come forward to say another man confessed to killing MacPhail. Further, there has been no physical evidence linking Davis, who had no prior criminal record, to the killing.

Restrictions on federal appeals prevented Davis from having a hearing in federal court on the reliability of the witness testimony used against him. The Georgia Board of Pardons and Paroles also rejected Davis’ application for clemency. An appellate court stayed Davis’ execution date so that his lawyers could file the appeals to the Supreme Court.

Davis was granted a stay of execution by the U.S. Supreme Court 2 hours before he was to be put to death in 2008, and the court in 2009 ordered the federal District Court to take another look at the case.

After holding a hearing to review evidence, the 11th Circuit Court of Appeals had ruled earlier that Davis "failed to show actual innocence" in the case. The District Court suggested that, for procedural reasons, Davis should take his appeal of its ruling directly to the Supreme Court.

In January, Davis’ lawyers filed two pleas. One sought review of the Georgia federal judge's rejection of the innocence claim, and the other asked for a test of the 11th Circuit's refusal to review the case.

"Nobody walking out of that hearing could view this as an open-and-shut case," Larry Cox, executive director of Amnesty International USA, told WSAV-TV after Monday’s Supreme Court ruling.

"The testimony that came to light demonstrates that doubt still exists, but the legal bar for proving innocence was set so high it was virtually insurmountable," said Cox. “It would be utterly unconscionable to proceed with this execution, plain and simple."

“I think the position of the state has been the burden of proof is on the defense since there’s been a determination in the process,” Rust-Tierney said. “But when all the legalese is pushed aside, the question is is there enough confidence in this conviction to go forward with an execution?”

Davis' sister told CNN Monday that she was "very disappointed" by the Supreme Court's rejection.

Martina Correia-Davis said Davis' attorney told her they would continue to pursue all possible legal options, including a possible repetition of the Georgia State Board of Parole.

MacPhail’s son, Mark MacPhail, Jr. told WSAV-TV in Savannah that the High Court’s ruling proved what the evidence has always shown and what his family has known all along: that "Troy Davis is guilty."

MacPhail, Jr., who was just a few months old when his father was slain, told the television station he had been getting somewhat frustrated and nervous and "wondering what was taking so long."

But Davis’ case has received broad support from entertainment, social and political figures, including former President Jimmy Carter and Pope Benedict XVI. There also have been calls for the Georgia Board of Pardons and Parole to commute Davis’ sentence.

It is unclear what Davis’ lawyers' options are, but defense attorney Jason Ewart told The Associated Press the likeliest route is appealing to the pardons and parole board, a five-member board that rarely postpones executions.

"The Troy Davis case is emblematic of everything that is wrong with capital punishment," Laura Moye, director of AIUSA's Death Penalty Abolition Campaign, told WSAV. "In a system rife with error, mistakes can be made.

“There are no do-overs when it comes to death," said Moye. “Lawmakers across the country should scrutinize this case carefully, not only because of its unprecedented nature, but because it clearly indicates the need to abolish the death penalty in the United States."

Source: BlackAmericaWeb.com, March 30, 2011


Why the war to save Troy Davis isn't over

On March 28, 2011 I woke up elated about my 10 year anniversary as a cancer survivor. I looked outside and it was cold and gloomy, the sun was nowhere to be found. It's about 9:30 a.m. and the phone rings, it's my brother Troy Davis' lawyer and from the tone in his voice I knew, it was not good news.

My heart sank to a heavy place as I listened to his monotone voice saying, "We just received news that the United States Supreme Court has denied Troy's appeal." Knowing that the appeals for Troy have always been an uphill battle and the lawyers have always stated that from a legal standpoint. Yet today I also heard optimism in the statement, "We will seek and exhaust all legal means available to us." I know from a legal standpoint denial by the Supreme Court is nothing a lawyer finds optimism in, yet I felt the readiness for yet another battle.

My first concern was my mother and my brother Troy. I cannot imagine facing three execution dates and the possibility of a fourth. I knew Troy would be more concerned about our family than himself, but I also knew that as much faith and spirituality as my mother has, she is still a mother and we are fighting for my brother's very existence. In this fight Troy is no longer voiceless and my family is no longer invisible, yet the court still refuses to hear what we have to say. Innocence does matter and beyond a reasonable doubt should be of utmost.

One thing for certain is that the global concern about this case is growing and yet the highest court in the United States is not willing to address the issue of innocence and new evidence. We live in country that is supposed to promote democracy and human rights for other countries yet it is not unconstitutional for us to execute innocent people in the U.S. if the courts feel they received a fair trial.

I am both enraged and empowered, for this battle to save Troy is a war of life and death for me! Until there is no breath left in my body I will fight for Troy, fight against the injustice of the death penalty, because this battle is bigger than Troy it is a war against a system is not impartial, a system that cares less for fairness and more for finality. In no way have we ever diminished the loss and hurt of the McPhail family, yet both families have been victimized. Being a mother and having Stage 4 cancer I understand the importance of life and I am willing to give my life to spare my brother's. No matter the final outcome of this case, my war against the death penalty is far from over and I will no longer be a victimize by this system in the United States, that justice depends on your ability to pay for it.

The hearing held in June 2010 in Savannah was like a puppet show, it was entertaining to some, upsetting to others, yet once the judge opened his mouth and looked at my brother with disgust I knew that no matter what Troy's lawyers had to present the judge had already made his decision to deny Troy, so he was just going through the motions like a puppeteer. I saluted the witnesses, even though they were criminalized by the state prosecutor for recanting their trial testimony. When they testified against Troy all those years ago, the police treated them like heroes, even though they had the same criminal history in 1989. It also seemed amazing that all the police who testified had amnesia about their role of misconduct with the witnesses, yet the judge chose to believe them over recanted testimony of the very witnesses they used to secure a conviction and death sentence for my brother.

The Georgia Parole Board said they will not execute when there is doubt. The case of Troy Anthony Davis is full of doubt.

As Troy said to me, "It's not over 'til God says it's over, this fight for justice did not begin with me and will not end with me."

The battle for Justice and the War to save Troy wages on! My name is Martina Correia and I am on Death Row because that is where my brother lives, our lives intertwined. If Troy is executed he will become even more powerful, because people all around the world are saying, "I AM TROY DAVIS," and his story will be heard.

Source: Opinion, Martina Correia, The Grio, April 3, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.